Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Inhibitors of tumor cell proliferation patented by Roche

Oct. 15, 1999

NuChem's anticancer drug candidates to be featured at upcoming oncology meeting

Oct. 14, 1999

Disappointing results reported from phase III lisofylline trial

Oct. 14, 1999

Vion to commence phase I trial of VNP-20009

Oct. 14, 1999

ImClone Systems initiates enrollment in phase II C225/CPT-11 trial

Oct. 13, 1999

SU-5416: promising phase I findings presented at ICAAC; update on clinical status

Oct. 13, 1999

Nonpeptide modulators of GnRH release patented by Alanex

Oct. 13, 1999

New British Biotech esters inhibit tumor cell proliferation

Oct. 12, 1999

Gemin X discovers novel Bcl-2 inhibitor as anticancer agent

Oct. 12, 1999

EM-800 unexpectedly found to resemble raloxifene more closely than fulvestrant

Oct. 12, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...